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Abstract 
In this paper, we present the rare case of a patient with cervical lymphadenopathy 
diagnosed as a T-cell-rich B-cell non-Hodgkin lymphoma that manifested Horner’s syndrome 
due to a post-ganglionic sympathetic neuron lesion caused by the tumor. 
 
Introduction 
Sympathetic innervation of the eye is a third-order neuron pathway which emerges 
from the hypothalamus and runs along a well-known route before reaching the eye [1–
3]. The third-order neuron is located in the superior cervical ganglion dividing itself 
into two branches which innervate the Müller’s muscle of the eyelids, lacrimal gland, 
iris dilator muscle, facial sweat glands and the small skin vessels [1–3]. Horner’s 
syndrome, also called oculosympathetic paresis, results from any lesion that interrupts 
the sympathetic neuronal pathway from the hypothalamus to the eye. It manifests 
ipsilaterally to the lesion, consisting mainly of miosis, slight ptosis and enophthalmos, 
but can present other findings [1–3]. Horner’s syndrome can be caused by many benign 
and malignant conditions [1–4]. Neoplasia is the most common cause and accounts for 
35–60% of all cases [2–4]. Non-Hodgkin lymphomas, however, are uncommonly related 
to this syndrome. The purpose of this paper is to present the case of a woman with a 
left cervical mass corresponding to a T-cell-rich B-cell non-Hodgkin lymphoma that 
manifested Horner’s syndrome due to a sympathetic third-order neuron lesion at 
diagnosis. To our knowledge, this is the first case of Horner’s syndrome secondary to a  
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lesion in the post-ganglionic level of the sympathetic pathway in a non-Hodgkin 
lymphoma. 
Case Report 
A 35-year-old woman was admitted with a cervical lymphadenopathy which had progressively 
grown over the last 3 months. It consisted of a coalescent group of hard lymph nodes that infiltrated 
adjacent tissues and skin, posteriorly located on the left side of the neck (fig. 1a). Simultaneously she 
presented ipsilateral miosis, slight superior eyelid ptosis, and enophthalmos typical for Horner’s 
syndrome (fig. 1b). She did not present hemifacial anhydrosis or flushing. The ocular phenylephrine 
1%-test revealed minimal dilatation in the normal right pupil and pronounced dilatation in the left 
affected pupil (fig. 1c). CT scan of the neck confirmed a lymphadenopathy that occupied the carotid 
and paravertebral spaces. Thoracic CT scan did not show any tumor in the mediastine or left lung 
apex. Cervical tumor biopsy revealed a T-cell-rich B-cell non-Hodgkin lymphoma 
[immunohistochemistry: 100% large lymphocytes CD20(+); 40% large lymphocytes CD45(+); 
background lymphocytes CD3(+); CD15(–); CD30(–); ALK-1(–)]. As liver and bone marrow were both 
compromised but without B symptoms, the tumor was classified as stage IVA by the Ann Arbor 
Staging System, and she was treated with 6 cycles of R-CHOP. Until present, the patient has been 
receiving salvage chemotherapy with ifosfamide, carboplatin and etoposide due to a relapse affecting 
the lungs occurring after 2 years of complete clinical remission. As soon as she reaches the second 
remission, she will undergo an autologous bone marrow transplant. 
Discussion 
We found a small number of papers citing or describing Horner’s syndrome related 
to non-Hodgkin lymphomas [5–9]. They were reported as tumors that primarily 
affected the intramedullary spinal cord (C3-C6) [9], lung apex (Pancoast’s syndrome 
presentation) [6, 7], the thyroid gland [5], or which were spread throughout the 
patient’s body including a supraclavicular lymphadenopathy [8]. These published cases, 
however, seem to be the result of sympathetic neuronal pathway interruption in the 
first- [9] or second-order neuron pathways [6–8]. In 1958, Giles and Henderson [4] 
cited a case of malignant lymphoblastoma that caused Horner’s syndrome in one of 
their study patients. This tumor could correspond to a non-Hodgkin lymphoma, but the 
sympathetic lesion level was not specified [4]. According to Danesh-Meyer et al. [10], 
the phenylephrine test finding observed in our patient locates the lesion in the third-
order neuron level (post-ganglionic). This can be explained by the principle of 
denervation supersensitivity which occurs in the affected side. As the patient did not 
show hemifacial anhydrosis or flushing, it seems that the lesion specifically affected the 
third-order neural branch along the internal carotid artery [3]. 
It is well-known that neck lymphadenopathy from any cause can result in Horner’s 
syndrome [3]. Nonetheless, our paper illustrates a rare presentation of non-Hodgkin 
lymphoma, mainly because it seems to be the first well-documented case of a third-
order sympathetic neuron lesion caused by this kind of malignancy. 
 
 
 
  
Case Rep Neurol 2012;4:43–46 
DOI: 10.1159/000335521 
Published online: 
February 3, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–680X 
www.karger.com/crn 
 
 
 
45 
 
Fig. 1. a Tumor mass consisting of coalescent hard lymph nodes that have infiltrated adjacent tissues 
and skin, posteriorly located on the left side of the neck. b Myosis, slight upper eyelid ptosis, and 
enophthalmos characterizing Horner’s syndrome in the left eye. c The phenylephrine 1% test shows 
bilateral mydriasis which is more pronounced in the affected left pupil than in the non-affected right 
pupil. The test results locate the lesion in the third-order neuron level (post-ganglionic). 
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